tG1, which contained only mesenchymal organoids, showed the most robust enrichment for mesenchymal development (EMT and mesenchymal cell differentiation) as well as cancer-ECM interactions (cell-substrate adhesion, cell-matrix adhesion, cellular response to growth factor/TGF-β stimulus). This evidence concerns the gene TGFB1 and cancer.